Dr. Firas Rabbat, MD

Dr. Rabbat practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Rabbat's NPI, 1831571611, was assigned on June 29, 2015. Dr. Rabbat graduated from University of Aleppo Faculty of Medicine in 2014. Dr. Rabbat holds Florida license 150587.

Dr. Rabbat's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Rabbat's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. The medical group on file is Providence Medical Group, Oregon. Dmand AI also links Dr. Rabbat to 7 more medical groups, 2 group practices and clinics, 1 breast imaging center and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rabbat practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Rabbat's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Rabbat is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rabbat's licenses on file in 10 states: Florida, Alaska, California, Idaho, Montana, New Mexico, Washington, Oregon, Texas and North Carolina.

Dmand AI lists acute respiratory failure, cardiac arrhythmia, cellulitis, chest pain, congestive heart failure, electrolyte disorders, gastrointestinal bleeding and gastrointestinal infection among the conditions Dr. Rabbat treats.

CMS data shows 368 Medicare services from Dr. Rabbat across 4 procedure codes in 2024, for 200 Medicare patients. Medicare paid $36,043 for them.

CMS counts 200 Medicare patients who saw Dr. Rabbat in 2024. The largest group is 75 to 84, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 3.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rabbat's median patient age at 70, with 53% women.

In 2024, Dr. Rabbat wrote 135 Medicare Part D claims for 74 patients. 88% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $76 in total drug cost. In 2023, CMS named 94 claims across 7 drugs.

Dr. Rabbat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rabbat as offering telehealth.

Dmand AI links 3 papers to Dr. Rabbat, published from 2018 to 2022. 2022 was the busiest year, with 2. Dr. Rabbat's most frequent co-authors are M. Chadi Alraies, MD, Yasser Sa D Abdelrahman Al-Khadra, MD and Fahed Darmoch.

CMS Open Payments shows 1 general payment to Dr. Rabbat from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $122.

Dr. Rabbat graduated from University of Aleppo Faculty of Medicine in 2014.

Dr. Rabbat is in network with 14 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.